Pancreatic Cancer Therapy Market: Rise in Number of Patients Suffering with Pancreatic Cancer
Download sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPMD00002009/?openpr-10144
The pancreatic cancer therapy market is expected to reach US$ 4056.4 million by 2025 from US$ 2011.2 million in 2017; it is estimated to grow at a CAGR of 8.1% from 2018 to 2025.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Merck & Co., Inc
Pharmacyte Biotech Inc
Teva Pharmaceutical Industries Ltd
Pancreatic cancer begins when the cells in the pancreas grow uncontrollably. Based on the type of cell affected, pancreatic cancer can be classified into two types, exocrine tumors, and endocrine tumors. These tumors behave differently. Hence they are treated differently. Pancreatic cancer generally diagnosed at a later stage since the symptoms are not easily detected or diagnosed. Factors such as chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity are some of the identified causes of pancreatic cancer. The pancreatic cancer therapy market growth is attributed to factors such as rise in number of patients suffering with pancreatic cancer, increasing healthcare expenditures for pancreatic drugs and increase in number of therapies launched in the market. Additionally, development of efficient therapy for pancreatic cancer treatment is expected to stimulate the market during the forecast period. However, side effects of the therapies and low success rate of treatments are expected to restrain the market of pancreatic cancer therapy.
For instance, the American Cancer Society suggests that pancreatic cancer accounts for approximately 3% of deaths of all cancers in the US. According to the National Institute of Health, an estimated of 68,615 patients in 2015 were living with pancreatic cancer in the US. The increasing incidence and prevalence of pancreatic cancer are expected to increase the demand for drugs, therapies, and treatment of patients. Moreover, the rising number of patients results in advancements in molecular biology and chemical drug formulation. Thus, a huge pool of patients who have pancreatic cancer is expected to increase the growth of the global pancreatic cancer therapy market over the forecast years.
Based on type, the pancreatic cancer therapy market is segmented into endocrine pancreatic cancer and exocrine pancreatic cancer. In 2017, the exocrine pancreatic cancer segment held the largest share of the market, by type. The exocrine pancreatic cancer segment is expected to grow at the fastest rate during the coming years as this type of cancer is the most common and majorly occurring type and thus is expected to have massive patient pool over the forecast years.
Based on therapy, the pancreatic cancer therapy market is segmented into biologic therapy, chemotherapy, and others. In 2017, biologic therapy segment held the largest share of the market, by therapy. Moreover, the biologic therapy segment is expected to grow at the fastest rate during the coming years owing to increasing number of novel upcoming immunotherapies as well as targeted cell therapy that treats the cancer without any severe side effects and has number of therapeutic benefits over the conventional chemotherapies.
Purchase Full Copy @ https://www.theinsightpartners.com/buy/TIPMD00002009/?openpr-10144
An outline of the regional analysis:
• Geographically, the report segments the Pancreatic Cancer Therapy market into North America, Europe, Asia-Pacific, Southeast Asia, Middle East and Africa, South America.
• Contribution of each region to the overall market share, along with their growth rate forecast are mentioned in the report.
• Total sales and revenue generated by each regional market are illustrated.
• Comprehensive assessment of all opportunities and risks in the Pancreatic Cancer Therapy market.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pancreatic Cancer Therapy Market: Rise in Number of Patients Suffering with Pancreatic Cancer here
News-ID: 2163088 • Views: 613
More Releases from The Insight Partners
Friction Modifiers Market -6-7 Year industry Performance Predictions, Technologi …
"Friction Modifiers Market Forecast to 2028" a detailed analysis report added by the insight partners. This report offers in-depth analysis of Friction Modifiers Market. It Consist 6-7 Year industry Performance Predictions, Market players Financial Performance, Strategic Developments & Key Insights. This reports also gives the analysis of industry size, share, demand and future opportunities to 2028 The report has been curated after observing and studying various factors that determine regional growth
Coated Steel Market Size, Industry Growth, Share, and Futuristic Developments Du …
Coated Steel Market the new research report adds to The Insight Partners database. This Research Report is spread Top companies, with tables and figures. Coated Steel Market analysis document is created by thoroughly understanding the business environment that best suits the client's requirements. With this market research document, it becomes easy to develop a successful marketing strategy for the business. This industry report is a complete overview of the market
Active Insulation Market Analysis by Industry Perspective, Comprehensive Analysi …
Active Insulation Market the new research report adds to The Insight Partners database. This Research Report is spread Top companies, with tables and figures. Active Insulation Market analysis document is created by thoroughly understanding the business environment that best suits the client's requirements. With this market research document, it becomes easy to develop a successful marketing strategy for the business. This industry report is a complete overview of the market
Hot Chocolate Powder Market Size, Value, CAGR, Analysis Forecast to 2028
The report aims to provide an overview of the "Hot Chocolate Powder Market" with detailed market segmentation. Also, it analyses the current market scenario and forecasts the market till 2028. The report covers market dynamics affecting the market during the forecast period. Furthermore, the report analyses the competitive scenario, geographic trends, and opportunities in the markets for all geographic regions. The report also includes detailed company profiles of the key
More Releases for Pancreatic
Pancreatic Cancer Treatment
Pancreatic Cancer Treatment Market describes its growth, size, share, Forecast and trends to 2025 Pancreatic Cancer Treatment Market Production and Demand Analysis 2019 to 2025 Pancreatic Cancer Treatment Market 2019 Manufacturing Analysis and Development Forecast 2025 Pancreatic Cancer Treatment Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Pancreatic Market to Insight By 2025: Top Key Vendors Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease. Download the sample report at: https://www.pharmaproff.com/request-sample/1024 Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI
Pancreatic Cancer Pipeline Review H1 2019
Pancreatic Cancer - Pipeline Review, H1 2017 Summary Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H1 2017, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and
Pancreatic Cancer Drug Pipeline Analysis
“Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Pancreatic Cancer. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each
Exocrine Pancreatic Insufficiency Market 2013
Transparency Market Research has published a new market report titled, “Exocrine Pancreatic Insufficiency Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 – 2023.” According to the report, the exocrine pancreatic insufficiency market is anticipated to expand at a CAGR of 8.3% from 2015 to 2023 to reach US$2.85 Bn by 2023. Browse the full Exocrine Pancreatic Insufficiency Market – (Therapeutic – Pancreatic Enzyme Replacement Therapy (Creon, Zenpep,
Research Announces: Global Pancreatic Cancer Market
MarketResearchReports.Biz is providing you Retail Market Research report of "Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017". Latest Report, Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Pancreatic Cancer Report is to understand the market and pipeline status of the drugs